Cargando…

Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study

BACKGROUND: Tenofovir (TDF) is part of the WHO recommended first-line antiretroviral therapy (ART); however, there are limited data comparing TDF to other nucleoside reverse transcriptase inhibitors in resource-limited-settings. Using a routine workplace and community-based ART cohort in South Afric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velen, Kavindhran, Lewis, James J., Charalambous, Salome, Grant, Alison D., Churchyard, Gavin J., Hoffmann, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653880/ https://www.ncbi.nlm.nih.gov/pubmed/23691224 http://dx.doi.org/10.1371/journal.pone.0064459

Ejemplares similares

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19
por: Chimoyi, Lucy, et al.
Publicado: (2020)

Household HIV Testing Uptake among Contacts of TB Patients in South Africa
por: Velen, Kavindhran, et al.
Publicado: (2016)

Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment
por: Phe, Thong, et al.
Publicado: (2013)

Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa
por: Velen, Kavindhran, et al.
Publicado: (2021)

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
por: Gray, Lachlan R., et al.
Publicado: (2013)

Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa
por: Page-Shipp, Liesl, et al.
Publicado: (2018)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
por: Manosuthi, Weerawat, et al.
Publicado: (2010)

Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa
por: Ntshiqa, Thobani, et al.
Publicado: (2022)

Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti
por: Pierre, Samuel, et al.
Publicado: (2021)

Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study
por: Russell, Elizabeth C, et al.
Publicado: (2010)

“Knock Knock”: a qualitative study exploring the experience of household contacts on home visits and their attitude towards people living with TB in South Africa
por: Sathar, Farzana, et al.
Publicado: (2020)

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010)

Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

Human resource time commitments and associated costs of Community Caregiver outreach team operations in South Africa
por: Mukora, Rachel, et al.
Publicado: (2023)

Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome
por: Johnston, Victoria, et al.
Publicado: (2012)

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
por: von Wyl, Viktor, et al.
Publicado: (2012)

Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients
por: Subashini, Dhakshinamoorthy, et al.
Publicado: (2018)

Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
por: Dahab, Mison, et al.
Publicado: (2010)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial
por: Mulenga, Veronica, et al.
Publicado: (2016)

Incidence of Treatment-Limiting Toxicity with Stavudine-Based Antiretroviral Therapy in Cambodia: A Retrospective Cohort Study
por: Phan, Vichet, et al.
Publicado: (2012)

Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial
por: Fielding, Katherine L, et al.
Publicado: (2015)

Exploring the promise and reality of ward-based primary healthcare outreach teams conducting TB household contact tracing in three districts of South Africa
por: Chetty-Makkan, Candice M., et al.
Publicado: (2021)

A qualitative exploration into the presence of TB stigmatization across three districts in South Africa
por: DeSanto, Daniel, et al.
Publicado: (2023)

Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners
por: Chihota, Violet N., et al.
Publicado: (2022)

Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study
por: Fielding, Katherine L, et al.
Publicado: (2008)

Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir
por: Vos, Alinda G., et al.
Publicado: (2018)

Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa
por: Fielding, Katherine, et al.
Publicado: (2011)

Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
por: Johnston, Victoria, et al.
Publicado: (2014)

Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir
por: Vivanti, Alexandre, et al.
Publicado: (2015)

Incidence of HIV-Associated Tuberculosis among Individuals Taking Combination Antiretroviral Therapy: A Systematic Review and Meta-Analysis
por: Kufa, Tendesayi, et al.
Publicado: (2014)

Zidovudine.
por: Sperling, R
Publicado: (1998)

Nucleoside reverse transcriptase inhibitors (zidovudine and stavudine) side-effects in people living with human immunodeficiency virus/acquired immunodeficiency syndrome attending the antiretroviral treatment center of B.J. Medical College and Civil Hospital at Ahmedabad, Gujarat, India
por: Shah, Asha N., et al.
Publicado: (2013)

Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults
por: Badii, Vitus Sambo, et al.
Publicado: (2018)

"That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
por: Dahab, Mison, et al.
Publicado: (2008)

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
por: Innes, Steve, et al.
Publicado: (2018)

Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients
por: Salazar-Austin, Nicole, et al.
Publicado: (2022)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

Post-dispensing stability surveillance: Stavudine
por: Naidoo, Kamsaladevi K., et al.
Publicado: (2009)

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
por: Venter, Willem Daniel Francois, et al.
Publicado: (2019)

Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy
por: Pujades-Rodríguez, Mar, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_42th6gi8l7rfb2lglrng7r3i1q